You are here
Welcome and introduction: An overview of the current prostate cancer treatment landscape
For localized prostate cancer, Dr Montorsi explains that local treatment is likely to be beneficial in most patients. For node-positive or metastatic prostate cancer, androgen deprivation therapy is appropriate, preferably with docetaxel. For metastatic castrate-resistant prostate cancer, chemotherapy including docetaxel may prolong survival; options are increased by novel agents targeting the androgen receptor.